BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NextConsensus//Registered forecast deadlines//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:FF-056 deadline
X-WR-CALDESC:Event deadlines of registered forecasts. Dates\, names\, and l
 inks only.
REFRESH-INTERVAL;VALUE=DURATION:P1D
X-PUBLISHED-TTL:PT24H
BEGIN:VEVENT
UID:ff-056@nextconsensus.com
DTSTAMP:20261026T000000Z
DTSTART;VALUE=DATE:20270223
DTEND;VALUE=DATE:20270224
SUMMARY:FF-056 deadline: Roflumilast cream · infant atopic dermatitis supp
 lement approval
DESCRIPTION:Registered forecast FF-056 (FDA)\, Roflumilast cream · infant 
 atopic dermatitis supplement approval. It asks whether this happens by 202
 7-02-23. The record: https://nextconsensus.com/forecast/ff-056/
URL:https://nextconsensus.com/forecast/ff-056/
CATEGORIES:Registered forecast,FDA
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR